News2023-12-12T21:03:55+00:00

Laidlaw served as Co-Manager on the $129,000,000 Common Stock and Concurrent Private Placement for Soleno Therapeutics (SLNO)

December 5th, 2023|

Laidlaw acts as Co-Manager on the $287,500,000 Follow-On Offering for Viking Therapeutics.

March 31st, 2023|
Go to Top